Promise of pharmacogenomics in smoking cessation

Pharmacogenomics

Volumn 10, Issue 7, 2009, Pages 1123-1125

  Uhl, George R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DOPAMINE TRANSPORTER; NICOTINE DERIVATIVE; NICOTINIC RECEPTOR; VARENICLINE;

CIGARETTE SMOKING; DRUG TARGETING; EDITORIAL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; NICOTINE REPLACEMENT THERAPY; PHARMACOGENOMICS; RECURRENCE RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; TOBACCO DEPENDENCE;

GENETIC VARIATION; GENOTYPE; HUMANS; PHARMACOGENETICS; SMOKING; SMOKING CESSATION;

EID: 70449503609     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.09.87     Document Type: Editorial

References (14)

1. Broms U, Silventoinen K, Madden PA, Heath AC, Kaprio J: Genetic architecture of smoking behavior: a study of Finnish adult twins. Twin Res. Hum. Genet. 9(1), 64-72 (2006). (Pubitemid 43384794)
2. Lessov CN, Martin NG, Statham DJ et al.: Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol. Med. 34(5), 865-879 (2004).
3. Adhikari B, Kahende J, Malarcher A, Pechacek T, Tong V: Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. Morb. Mortal. Wkly Rep. 57(45), 1226-1228 (2008).
4. Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP: Smoking cessation with and without assistance: a population-based ana lysis. Am. J. Prev. Med. 18(4), 305-311 (2000). (Pubitemid 30224565)
5. Drgon T, Montoya I, Johnson C et al.: Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol. Med. 15(1-2), 21-27 (2009).
6. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE: Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. BMC Genet. 8, 10 (2007). (Pubitemid 46629633)
7. Uhl GR, Liu QR, Drgon T et al.: Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch. Gen. Psychiatry 65(6), 683-693 (2008). (Pubitemid 351787239)
8. Uhl GR, Drgon T, Johnson C et al.: 'Higher order' addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75(1), 98-111 (2008). (Pubitemid 350235391)
9. Saccone NL, Saccone SF, Hinrichs AL et al.: Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B(4), 453-466 (2009).
10. Bierut LJ, Madden PA, Breslau N et al.: Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16(1), 24-35 (2007). (Pubitemid 46152542)
11. Saccone SF, Hinrichs AL, Saccone NL et al.: Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 16(1), 36-49 (2007).
12. Rose JE, Herskovic JE, Behm FM, Westman EC: Pre-cessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Nicotine Tob. Res. (2009) (In press).
13. Uhl GR, Drgon T, Johnson C, Rose JE: Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials. Pharmacogenomics J. 9(2), 111-115 (2008).
14. Applying Genomics to Clinical Problems - Diagnostics, Preventive Medicine, Pharmacogenomics www.genome.gov/27529204